PDLIM2 and hepatocellular carcinoma: Especially in hepatocellular carcinoma (HCC), Jiang and colleagues illustrated a reduction in PDLIM2 expression in both tissue samples and cells, which was associated with an unfavorable prognosis for individuals diagnosed with HCC [37].